Medication Monitor



Generic Name (Trade Name—Company)
Notes
May 1, 2011

Meningococcal (Groups A, C, Y, and W-135) polysaccharide diphtheria toxoid conjugate vaccine

(Menactra—Sanofi Pasteur)
Immunization for children 9 to 23 months of age

Uses:

Immunization for children 9 to 23 months of age

Data from one Phase II and three Phase III studies involving more than 3,300 infants showed that two doses of the vaccine given 3 months apart elicited a robust immune response against the serogroups in the vaccine. In addition, data from these studies showed that the measles-mumps-rubella-varicella vaccine and pneumococcal conjugate vaccine can be administered at the same as Menactra in children. The most common adverse events included injection-site reactions (i.e., swelling and tenderness) and irritability.